B
VRTX icon

Bensler’s Vertex Pharmaceuticals VRTX Stock Holding History

Bensler’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.23M Buy
8,506
+250
+3% +$111K 0.37% 57
2026
Q1 		$3.69M Sell
8,256
-490
-6% -$228K 0.38% 64
2025
Q4 		$3.96M Sell
8,746
-90
-1% -$38.8K 0.4% 62
2025
Q3 		$3.46M Buy
8,836
+41
+0.5% +$17.1K 0.36% 62
2025
Q2 		$3.92M Sell
8,795
-40
-0.5% -$18.4K 0.44% 60
2025
Q1 		$4.28M Sell
8,835
-133
-1% -$62K 0.54% 51
2024
Q4 		$3.61M Sell
8,968
-325
-3% -$151K 0.43% 60
2024
Q3 		$4.32M Sell
9,293
-48
-0.5% -$23.1K 0.55% 53
2024
Q2 		$4.38M Buy
9,341
+57
+0.6% +$24.7K 0.59% 50
2024
Q1 		$3.88M Buy
9,284
+206
+2% +$87.1K 0.56% 55
2023
Q4 		$3.69M Sell
9,078
-113
-1% -$41.7K 0.61% 52
2023
Q3 		$3.2M Buy
9,191
+50
+0.5% +$17.5K 0.62% 54
2023
Q2 		$3.22M Sell
9,141
-10
-0.1% -$3.37K 0.61% 57
2023
Q1 		$2.88M Buy
9,151
+192
+2% +$57.6K 0.58% 60
2022
Q4 		$2.59M Buy
8,959
+11
+0.1% +$3.35K 0.58% 61
2022
Q3 		$2.59M Buy
8,948
+231
+3% +$66.5K 0.62% 55
2022
Q2 		$2.46M Buy
8,717
+42
+0.5% +$11.2K 0.58% 58
2022
Q1 		$2.26M Buy
8,675
+10
+0.1% +$2.37K 0.48% 71
2021
Q4 		$1.9M Buy
+8,665
New +$1.68M 0.53% 62

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Bensler's VRTX Position: Q2 2026 in Review

Bensler increased its Vertex Pharmaceuticals (VRTX) stake by 3% in Q2 2026, buying an estimated $111K and bringing the position to 8,506 shares worth $4.23M. The position accounts for 0.37% of the portfolio, ranked #57.

Bensler first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.38M in Q2 2024. 537 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Bensler held 8,506 shares of Vertex Pharmaceuticals worth $4.23M as of Q2 2026.
  • Bensler bought 250 Vertex Pharmaceuticals shares in Q2 2026, an estimated $111K.
  • Vertex Pharmaceuticals made up 0.37% of Bensler's portfolio in Q2 2026, its #57 holding.
  • Bensler first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Bensler's Vertex Pharmaceuticals position peaked at $4.38M in Q2 2024.
  • 537 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Bensler's 13F filing for Q2 2026, filed 23 Jul 2026.